Literature DB >> 2921777

Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis.

G Kovacs1, L Wilkens, T Papp, W de Riese.   

Abstract

Recent studies have shown that the deletion of chromosome 3p or the loss of DNA sequences at 3p is generally associated with the development of renal cell carcinoma (RCC). However, chromosome analysis of some papillary RCCs suggested that this type of tumor differs genotypically from the most common nonpapillary RCCs. Therefore, by using cytogenetic and molecular genetic approaches, we examined human papillary and nonpapillary RCCs for the loss of heterozygosity or homozygosity at the short arm of chromosome 3. The constitutional heterozygosity for the DNF15S2 locus and for one allele of the c-erbA beta and the c-raf-1 proto-oncogenes was lost in nonpapillary RCCs, whereas both alleles were retained in each papillary RCC analyzed. We conclude that the loss of DNA sequences at the chromosome 3p region is a genomic change occurring consistently in nonpapillary RCCs, but never occurring in papillary RCCs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2921777     DOI: 10.1093/jnci/81.7.527

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  12 in total

Review 1.  Application of molecular cytogenetic techniques to the evaluation of renal parenchymal tumors.

Authors:  G Kovacs
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program.

Authors:  Brian Shuch; Jonathan N Hofmann; Maria J Merino; Jeffrey W Nix; Srinivas Vourganti; W Marston Linehan; Kendra Schwartz; Julie J Ruterbusch; Joanne S Colt; Mark P Purdue; Wong-Ho Chow
Journal:  Urol Oncol       Date:  2013-02-28       Impact factor: 3.498

3.  Accurate molecular classification of renal tumors using microRNA expression.

Authors:  Eddie Fridman; Zohar Dotan; Iris Barshack; Miriam Ben David; Avital Dov; Sarit Tabak; Orit Zion; Sima Benjamin; Hila Benjamin; Hagit Kuker; Camila Avivi; Kinneret Rosenblatt; Sylvie Polak-Charcon; Jacob Ramon; Nitzan Rosenfeld; Yael Spector
Journal:  J Mol Diagn       Date:  2010-07-01       Impact factor: 5.568

Review 4.  Renal cancer subtypes: Should we be lumping or splitting for therapeutic decision making?

Authors:  Scott M Haake; W Kimryn Rathmell
Journal:  Cancer       Date:  2016-11-14       Impact factor: 6.860

5.  Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis.

Authors:  P Bugert; G Kovacs
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

6.  Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes.

Authors:  C A Thrash-Bingham; R E Greenberg; S Howard; A Bruzel; M Bremer; A Goll; H Salazar; J J Freed; K D Tartof
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 7.  Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.

Authors:  Theodore F Logan
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

8.  A type 2 papillary renal cell carcinoma presenting as an intracystic necrotic lesion: A case report.

Authors:  Zhenyu Fu; Liguo Sun; Yuhua Huang; Jie Zhang; Zichao Zhang; Lijun Wang; Shengyu Wang; Ge Zhang
Journal:  Mol Clin Oncol       Date:  2013-01-11

9.  Familial renal cell carcinoma: clinical and molecular genetic aspects.

Authors:  E R Maher; J R Yates
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

10.  Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22.

Authors:  K Foster; P A Crossey; P Cairns; J W Hetherington; F M Richards; M H Jones; E Bentley; N A Affara; M A Ferguson-Smith; E R Maher
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.